کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
9382854 | 1278973 | 2005 | 4 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Drug-eluting stents reduce restenosis rates and major adverse cardiac events, but not mortality, in patients undergoing percutaneous coronary intervention
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
سیاست های بهداشت و سلامت عمومی
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Drug-eluting stents reduce restenosis rates and major adverse cardiac events, but not mortality, in patients undergoing percutaneous coronary intervention Drug-eluting stents reduce restenosis rates and major adverse cardiac events, but not mortality, in patients undergoing percutaneous coronary intervention](/preview/png/9382854.png)
چکیده انگلیسی
Stents that elute paclitaxel or sirolimus significantly lower the medium-term rates of restenosis and major adverse cardiac events compared with bare-metal stents in people who have percutaneous coronary intervention. The lower rate of major cardiovascular events is entirely due to a reduction in the rate of target-lesion revascularisation, as drug-eluting stents do not reduce the rate of heart attack or death.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Evidence-based Healthcare and Public Health - Volume 9, Issue 1, February 2005, Pages 16-19
Journal: Evidence-based Healthcare and Public Health - Volume 9, Issue 1, February 2005, Pages 16-19
نویسندگان
David F. MD, AM, FACC, FSCAI,